Scientific Program
Live Stream from Berlin – in Tv Quality
Chat Window: Discuss with us! Send us your questions and comments!
- Presidential Lectures
- Pro/Con Debates
- CMC Panel Discussions
- Symposia
Breast Cancer
- Surgical Topics of Breast Surgery and Reconstruction
and Presentation of Surgery Videos - CDK4/6 Inhibitors: Update on Survival Data in the
Metastatic Setting and Efficacy in the Adjuvant Setting - Immune Checkpoint Therapies for ER+ Breast Cancer:
New Evidence - New ER Targeted Therapies: SERDs, SERMs, PROTACs
and SERCAs - ADCs: When, Which, for Whom?
- Hormone Replacement Therapy: Newer Evidence
- New Vaccine Approaches for Prevention of Breast Cancer
Cervical Cancer
- Cervical Cancer Management: Yesterday, Today,
Tomorrow - Radical Hysterectomy, Simple Hysterectomy, or
Cone Biopsy in Early-stage Cervical Cancer - Surgery, Radiochemotherapy, or Incorporation
Immunotherapy in Primary Cervical Cancer? - Newest Options in Cervical Cancer
- The Most Challenging Case from the Clinical Routine
- Management of New Side Effects in Cervical Cancer
Management (Acute, Delayed, and Late)
Ovarian Cancer
- Ovarian Cancer Management: Yesterday, Today,
Tomorrow - Best Supportive Care Only or Chemotherapy or a
Specific Cancer Therapy? - HRD-related Therapies: PRIMA vs. Paola vs. Athena vs.
Ov-43 vs. Duo-O and More …
What is the Best Strategy? - Management of New Side Effects in Ovarian Cancer
Management (Acute, Delayed, and Late) - Lymph Node Resection in Primary and Relapsed Ovarian
Cancer? New Exclusive Data to Revise our Attitude - The Most Challenging Case from the Clinical Routine
Endometrial Cancer
- Endometrial Cancer Management: Yesterday, Today,
Tomorrow - What is Now the Best Therapy for Primary Endometrial
Cancer? - What is the Best Therapy for Relapsed Endometrial
Cancer? Chemotherapy Pretreated or Naïve? - Management of New Side Effects in Endometrial Cancer
Management (Acute, Delayed, and Late) - FIGO Staging
- Duo-E, Leap-001, NRG-18, RUBY, Garnet, KEYNOTE-158,
KEYNOTE-775, SIENDO, PALEO and More …
How to Integrate the Recent Milestone Trials into Clinical
Practice? - The Most Challenging Case from the Clinical Routine
Status: October 2023; may be subject to change